STORM believes in partnering as a strategic choice to innovate, create value and accelerate its pipeline. STORM has a close and interactive relationship with its scientific founders but will also seek and partner with the best scientists worldwide to underpin its drug discovery. The highest quality CRO partners are selected to aid our drug discovery in a mixed model of in house and outsourced activities. Furthermore, STORM recognises the value that larger pharmaceutical and biotechnology companies can bring in terms of expertise and resources and actively seeks partners for the growing number of discovery opportunities it has created from its discovery platform.

SOLD OUT - RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 17-20 September 2019

Find out more


  • Reuven Agami
  • Shankar Balasubramanian
  • Thomas Carell
  • Robert Copeland
  • Tom Cech
  • Michaela Frye
  • Francois Fuks
  • Richard Gregory
  • Chuan He
  • Stacy Horner
  • Samie Jaffrey
  • Narry Kim
  • Jeannie Lee
  • Michal Minczuk
  • Gidi Rechavi
  • Tom Suzuki